ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive: Bcl-6 – as a downstream target of FoxO3 has also been demonstrated to bind to and repress Arf and p53 promoters in BCR-ABL-positive ALL [74] and in CML [73•], which also compromises the p53 checkpoint (Fig. 1).